Complete response to bevacizumab plus irinotecan in patients with rapidly progressive GBM: Cases report and literature review
Journal of Oncological Sciences · 2016
DOI: 10.1016/j.jons.2016.07.009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Oncological Sciences, 2016. Verfasst von Oguz Ozel und 5 weiteren Autor:innen. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ozel, O., Kurt, M., Ozdemir, O., Bayram, J., Akdeniz, H., & Koca, D. (2016). Complete response to bevacizumab plus irinotecan in patients with rapidly progressive GBM: Cases report and literature review. Journal of Oncological Sciences. https://doi.org/10.1016/j.jons.2016.07.009
Vancouver
Ozel O, Kurt M, Ozdemir O, Bayram J, Akdeniz H, Koca D. Complete response to bevacizumab plus irinotecan in patients with rapidly progressive GBM: Cases report and literature review. Journal of Oncological Sciences. 2016. doi:10.1016/j.jons.2016.07.009
BibTeX
@article{Ozel2016,
author = {Ozel, Oguz and Kurt, Mehmet and Ozdemir, Oguzhan and Bayram, Jale and Akdeniz, Huseyin and Koca, Dogan},
title = {Complete response to bevacizumab plus irinotecan in patients with rapidly progressive GBM: Cases report and literature review},
journal = {Journal of Oncological Sciences},
year = {2016},
doi = {10.1016/j.jons.2016.07.009}
}
EUVIMED